Tien Liang BioTech Co., Ltd. (4127.TWO)
TWD 34.6
(-2.54%)
TWD 34.6
(-2.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 69.67 Million | 21.88 Million | 45.2 Million | -10.82 Million | - |
| Net Income | 18.41 Million | 59.32 Million | 48.78 Million | -48.59 Million | - |
| Depreciation & Amortization | 10.55 Million | 11.04 Million | 12.42 Million | 14.84 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 42.62 Million | -48.59 Million | -16.05 Million | 25.92 Million | - |
| Other non-cash items | 1.76 Million | 1.68 Million | 1.82 Million | -965 Thousand | - |
| Investing Cash Flow | -4.77 Million | -1.21 Million | -1.17 Million | 353 Thousand | - |
| Investments in PPE | -5.34 Million | -1.01 Million | -597 Thousand | -1.49 Million | - |
| Acquisitions | 600 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | -1000.00 |
| Sales/Maturities of investments | - | - | - | 1.2 Million | - |
| Other Investing Activities | -32 Thousand | -295 Thousand | -578 Thousand | 481 Thousand | - |
| Financing Cash Flow | -30.52 Million | -31.29 Million | -40.79 Million | 38.4 Million | - |
| Debt repayment | -30 Million | -30.5 Million | -40 Million | -39.06 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -529 Thousand | - | - | - | -2.37 Million |
| Accounts receivables | 22.01 Million | - | - | - | - |
| Accounts payables | -1.19 Million | - | - | - | - |
| Inventory | 19.17 Million | -34.01 Million | -8.36 Million | 5.24 Million | - |
| Other working capital | 1.43 Million | - | - | - | - |
| Cash at beginning of period | 107.84 Million | 118.46 Million | 115.23 Million | 87.29 Million | - |
| Cash at end of period | 142.21 Million | 107.84 Million | 118.46 Million | 115.23 Million | - |
| Capital Expenditure | -5.34 Million | -1.01 Million | -597 Thousand | -1.49 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 34.37 Million | -10.62 Million | 3.23 Million | 27.93 Million | - |
| Free Cash Flow | 64.33 Million | 20.87 Million | 44.6 Million | -12.31 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.04 Million | 7.5 Million | 8.34 Million | 18.41 Million | -1.59 Million | 6.14 Million |
| Depreciation & Amortization | 2.31 Million | 2.36 Million | 2.57 Million | 10.55 Million | 2.68 Million | 2.69 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -14 Million | 19.04 Million | 17.04 Million | 42.62 Million | 21.22 Million | 28.16 Million |
| Other non-cash items | -101 Thousand | 285 Thousand | 441 Thousand | 1.76 Million | -85 Thousand | 301 Thousand |
| Investing Cash Flow | -502 Thousand | -335 Thousand | 15 Thousand | -4.77 Million | -885 Thousand | -2.09 Million |
| Investments in PPE | -302 Thousand | -335 Thousand | 16 Thousand | -5.34 Million | -1.19 Million | -2.55 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -200 Thousand | - | -1000.00 | -32 Thousand | 169 Thousand | - |
| Financing Cash Flow | 34.87 Million | -126 Thousand | -30.12 Million | -30.52 Million | -126 Thousand | -125 Thousand |
| Debt repayment | -27.96 Million | - | -30 Million | -30 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -123 Thousand | - | - | - | - | - |
| Accounts receivables | 16.94 Million | - | - | - | - | - |
| Accounts payables | 1 Million | - | - | - | - | - |
| Inventory | -453 Thousand | 5 Million | 9.55 Million | 19.17 Million | 10.51 Million | 6.76 Million |
| Other working capital | -24.46 Million | - | - | - | - | - |
| Cash at beginning of period | 170.58 Million | 142.21 Million | 145.58 Million | 107.84 Million | 124.99 Million | 90.81 Million |
| Cash at end of period | 189.44 Million | 170.58 Million | 142.21 Million | 142.21 Million | 145.58 Million | 124.99 Million |
| Capital Expenditure | -302 Thousand | -335 Thousand | 16 Thousand | -5.34 Million | -1.19 Million | -2.55 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 18.86 Million | 28.36 Million | -3.36 Million | 34.37 Million | 20.58 Million | 34.18 Million |
| Free Cash Flow | -15.81 Million | 28.49 Million | 26.76 Million | 64.33 Million | 20.4 Million | 33.84 Million |
600939
1518
9412
GLAPY
SNR
5277